Therapeutic Asset Ratings

388 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
gsk1120212 Gangliocytoma	Novartis Pharmaceuticals	P4	BB (65)
gsk1120212 Ganglioglioma	Novartis Pharmaceuticals	P4	BB (65)
gsk1120212 Giant Cell Astrocytoma	Novartis Pharmaceuticals	P4	BB (65)
gsk1120212 Oligodendroglioma, Childhood	Novartis Pharmaceuticals	P4	BB (65)
gsk1120212 Papillary Glioneuronal Tumor	Novartis Pharmaceuticals	P4	BB (65)
gsk1120212 Pilocytic Astrocytoma	Novartis Pharmaceuticals	P4	BB (65)
gsk1120212 Pleomorphic Xanthoastrocytoma	Novartis Pharmaceuticals	P4	BB (65)
gsk1120212 Rosette-forming Glioneurona Tumor	Novartis Pharmaceuticals	P4	BB (65)
[18f]psma-1007 Prostate Cancer	Novartis Pharmaceuticals	P3	BB (65)
CTT-1057 Prostatic Neoplasms	Novartis Pharmaceuticals	P3	BB (65)
Hycamtin Neuroblastoma	Novartis Pharmaceuticals	P2	BB (65)
(+)-VINCRISTINE B Lymphoblastic Leukemia/Lymphoma With t(9;22)(q34.1;q11.2); BCR-ABL1	Novartis Pharmaceuticals	P2	BB (65)
CTT-1057 Prostate Cancer	Novartis Pharmaceuticals	P3	BB (64)
DEXAMETHASONE B Acute Lymphoblastic Leukemia, BCR-ABL1-Like	Novartis Pharmaceuticals	P3	BB (64)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION) Systemic Juvenile Idiopathic Arthritis	Novartis Pharmaceuticals	P3	BB (64)
lcz696 Hypertension	Novartis Pharmaceuticals	P3	BB (64)
Pelabresib Advanced Malignancies	Novartis Pharmaceuticals	P3	BB (64)
Siponimod Multiple Sclerosis, Relapsing-Remitting	Novartis Pharmaceuticals	P3	BB (64)
VIPIVOTIDE TETRAXETAN Prostatic Neoplasms	Novartis Pharmaceuticals	P3	BB (64)
FULVESTRANT Castration-resistant Prostate Cancer (CRPC)	Novartis Pharmaceuticals	P2	BB (64)
PIFLUFOLASTAT Prostate Cancer	Novartis Pharmaceuticals	P4	B (63)
(+)-VINCRISTINE Leukemia, Lymphoblastic, Acute, Philadelphia-Positive	Novartis Pharmaceuticals	P3	B (63)
Carboplatin Acute Coronary Syndrome	Novartis Pharmaceuticals	P4	B (62)
Cyclophosphamide Acute Coronary Syndrome	Novartis Pharmaceuticals	P4	B (62)
Ruxolitinib Thalassemia	Novartis Pharmaceuticals	P4	B (62)

Showing 51 to 75 of 388 assets

PreviousPage 3 of 16Next